Strategy question

Scale is standing up a net-new cybersecurity portfolio. How would you choose the first 2-3 capabilities to launch across vulnerability discovery, exploit reproduction, patch validation, secure code review, malware analysis, and incident triage? Walk through the prioritization framework you would use, including customer value, execution difficulty, benchmark credibility, and dual-use risk, and explain what you would explicitly defer from v1.

Practice this question out loud. An AI interviewer asks it, follows up like a real interviewer would, and scores your answer. Type or speak.

What this question tests

Tests prioritization judgment: picking a defensible, sequenced v1 from a wide capability space under real dual-use risk.

Clarify whether the buyer is frontier labs hardening their own models or enterprises buying tooling, since it changes the ranking.
Score each capability (discovery, exploit reproduction, patch validation, secure code review, malware analysis, incident triage) on willingness to pay, gradability, and benchmark credibility.
Weight execution difficulty: patch validation and code review are gradable now; exploit reproduction and malware analysis need heavier sandboxing.
Weight dual-use risk explicitly and down-rank exploit generation unless strong access controls exist.
Pick 2-3 capabilities that share infrastructure, like one sandboxed execution environment, so v1 investment compounds.
State what is deferred, such as malware analysis, and why: too risky or too costly to grade credibly today.

Names concrete picks, for example patch validation plus secure code review, because both reuse the same grading infrastructure and carry lower risk.
Ties the choice to Scale's existing human-verified labeling strength rather than treating this as green-field.
States an assumption, such as frontier labs as the first segment, and flags it as an assumption.

Chapters of the AI PM course that teach what this question tests.